TapewireFind a company

person · Reporting owner

Stacy Michelle

Disclosed activity across 2 companies

Tapewire entity
90111
SEC CIK
0001448355

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Decoy Therapeutics Inc.FLKS · Entity 937DirectorJuly 25, 2018July 26, 2018
IROBOT CORPIRBT · Entity 71819DirectorJune 07, 2024June 10, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Decoy Therapeutics Inc.

Report date July 25, 2018 · Filed July 26, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.82 · Expires 2028-07-25Direct10,000 Reported balance After 2018-07-25 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2018-07-25 · Grant · Acquired 10,000 · Balance 10,000

F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.

IROBOT CORP

Report date June 07, 2024 · Filed June 10, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect46,426 Reported balance After 2024-06-07 transaction · row 1
1 source row

Row 1 · 2024-06-07 · Grant · Acquired 20,986 · Balance 46,426

F1: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vests on the first anniversary of such grant.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vests on the first anniversary of such grant.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 07, 2024 Filed Jun 10, 2024 18:33 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 20,986 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071476 · ownership.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,426

F1 · kind: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vests on the first anniversary of such grant.

Read SEC document
June 09, 2023 Filed Jun 13, 2023 16:34 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 4,983 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-036721 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,440

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

F2 · balance_after: Includes 9,000 shares of the Issuer's Common Stock transferred from the reporting person's grantor retained annuity trust.

Read SEC document
June 10, 2022 Filed Jun 13, 2022 16:34 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 4,937 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-036333 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,457

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 21:07 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 1,826 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-040794 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,520

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 18:45 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 2,000 $124.00 $248,000.00
Disclosure

SEC source: 0001209191-21-005746 · doc4.xml · nonDerivative · entry 3

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,694

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 18:45 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,000 $114.00 $114,000.00
Disclosure

SEC source: 0001209191-21-005746 · doc4.xml · nonDerivative · entry 2

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 9,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 18:45 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,000 $104.00 $104,000.00
Disclosure

SEC source: 0001209191-21-005746 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 10,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.

Read SEC document
January 15, 2021 Filed Jan 20, 2021 17:45 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,000 $92.00 $92,000.00
Disclosure

SEC source: 0001209191-21-004429 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 11,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2020.

F2 · ownership.nature: Shares held by a grantor retained annuity trust, which reflect a contribution of 12,000 shares of the Issuer's common stock on December 7, 2020 by the reporting person.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 18:07 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 2,134 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035364 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,696

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document
June 07, 2019 Filed Jun 11, 2019 17:57 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 1,910 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-036168 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,562

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document
February 27, 2019 Filed Mar 1, 2019 18:13 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,500 $124.00 $186,000.00
Disclosure

SEC source: 0001209191-19-015173 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 4,998

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2018.

Read SEC document
February 12, 2019 Filed Feb 14, 2019 19:19 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,500 $114.00 $171,000.00
Disclosure

SEC source: 0001209191-19-010430 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By grantor retained annuity trust

Disclosed balance after: 6,498

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2018.

F2 · balance_after: Shares held by a grantor retained annuity trust, which reflect (i) a contribution on September 14, 2017 by the reporting person of 11,276 shares of the Issuer's Common Stock to the trust; (ii) a disposition on August 22, 2018 of 1,500 shares which was previously reported as a disposition by the reporting person directly; and (iii) an annuity distribution on November 9, 2018 from the trust to the reporting person of 1,778 shares, which shares continue to be reported in this Form 4 as directly owned.

Read SEC document
August 22, 2018 Filed Aug 23, 2018 17:46 UTC IROBOT CORP IRBT · Entity 71819 SaleCommon Stock 1,500 $103.42 $155,130.00
Disclosure

SEC source: 0001209191-18-048262 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,650

F1 · price: The range of prices for the transaction reported on this line was $103.41 to $103.47. The average weighted price was $103.42. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price

Read SEC document
July 25, 2018 Filed Jul 26, 2018 16:01 UTC Decoy Therapeutics Inc. FLKS · Entity 937 GrantStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $0.82 $0.00
Disclosure

SEC source: 0001615219-18-000045 · wf-form4_153263525068099.xml · derivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-07-25

F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018.

Read SEC document
June 08, 2018 Filed Jun 12, 2018 19:40 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 1,868 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-037334 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,150

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2018 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document
July 26, 2017 Filed Jul 27, 2017 08:54 UTC Decoy Therapeutics Inc. FLKS · Entity 937 GrantStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $4.08 $0.00
Disclosure

SEC source: 0001615219-17-000055 · wf-form4_150116003024208.xml · derivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2027-07-26

F1 · derivative.exercise_date: The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017.

Read SEC document
June 09, 2017 Filed Jun 13, 2017 17:54 UTC IROBOT CORP IRBT · Entity 71819 GrantCommon Stock 1,354 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-039632 · doc4.xml · nonDerivative · entry 1

Stacy Michelle · CIK 0001448355 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,282

F1 · shares: Consists of a restricted stock unit award made pursuant to the iRobot Corporation 2015 Stock Option and Incentive Plan. The restricted stock units vest (100%) on the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in no event later than 30 days after such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.